Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteral Glutamine Supplementation in Critical Illness
NCT00318331Phase 3Terminated
- Sponsor
- ChristianaCare
- Start
- May 2006
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of glutamine in critical illness, sepsis, Respiratory Insufficiency (RI), sponsored by ChristianaCare. Started May 2006; status: terminated.
02
Drugs
glutamine
03
Conditions
critical illnesssepsisRespiratory Insufficiency (RI)
Beyond the preview
Go deeper on NCT00318331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318331.